Mylene Martins Monteiro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mylene Martins Monteiro has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Eliete Neves Silva Guerra
Laboratory of Oral Histopathology, Health Sciences Faculty University of Brasilia Brasilia Brazil
6 shared publications - Juliana Amorim dos Santos
Laboratory of Oral Histopathology, Health Sciences Faculty University of Brasilia Brasilia Brazil
4 shared publications - Victor Paiva Barbosa
Laboratory of Oral Histopathology, Health Sciences Faculty University of Brasilia Brasilia Brazil
3 shared publications - Bruna Bastos Silveira
Laboratory of Oral Histopathology, Health Sciences Faculty University of Brasilia Brasilia Brazil
2 shared publications - Graziela De Luca Canto
Postgraduate Program in Evidence‐Based Health, Escola Paulista de Medicina Federal University of São Paulo São Paulo São Paulo Brazil
2 shared publications - Guilherme Martins Gelfuso
Laboratory of Food, Drugs, and Cosmetics (LTMAC), University of Brasilia, Brasília, Brazil
2 shared publications
Latest Publications
- 25 September 2025
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 39 (10) , e70515
Chitosan‐Based Systems for Curcumin Delivery: Evidence for Therapeutic Applications
Curcumin, a bioactive polyphenol from Curcuma longa, exhibits anti‐inflammatory, antioxidant, and anticancer effects. Despite its therapeutic promise, curcumin's clinical use is limited by poor water solubility and low bioavailability. Chitosan‐based delivery systems, especially polymeric nanoparticles, have been a strategy to improve curcumin's solubility, stability, and provide targeted drug delivery. This review maps evidence on the use of delivery systems based on the natural polymer chitosan incorporating curcumin for disease management, highlighting their potential to enhance therapeutic outcomes. The review included studies involving humans, animals, or cell cultures using chitosan‐based systems for curcumin delivery for therapeutical purposes. A systematic search was performed in PubMed, EMBASE, Web of Science Core Collection, and Google Scholar (January 16, 2025). Two independent reviewers selected studies, and data were synthesized descriptively. Bibliometric analysis was conducted using VOSviewer. From 5336 records, 387 studies met inclusion criteria. Cancer (212 studies) and wound healing (112 studies) were the predominant topics. Co‐occurrence analysis revealed curcumin, chitosan, and drug delivery as the main reported keywords. In cancer treatment, compiled evidence from in vitro and animal suggests that chitosan‐based nanoparticles enhanced curcumin's bioavailability, cytotoxicity, and therapeutic effect. The treatment was often applied in synergy with agents like 5‐fluorouracil, methotrexate, and paclitaxel. In wound healing, hydrogels, scaffolds, nanofibers, and films improved biocompatibility, antibacterial properties, and regenerative capacity, especially for diabetic wounds and burns. In some cases, the treatment incorporated other bioactives like EGF, exosomes, or aloe vera. Chitosan‐based formulations containing curcumin have demonstrated strong potential in cancer treatment and wound healing care.
- 25 September 2025
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 39 (10) , e70515
Chitosan‐Based Systems for Curcumin Delivery: Evidence for Therapeutic Applications
Curcumin, a bioactive polyphenol from Curcuma longa, exhibits anti‐inflammatory, antioxidant, and anticancer effects. Despite its therapeutic promise, curcumin's clinical use is limited by poor water solubility and low bioavailability. Chitosan‐based delivery systems, especially polymeric nanoparticles, have been a strategy to improve curcumin's solubility, stability, and provide targeted drug delivery. This review maps evidence on the use of delivery systems based on the natural polymer chitosan incorporating curcumin for disease management, highlighting their potential to enhance therapeutic outcomes. The review included studies involving humans, animals, or cell cultures using chitosan‐based systems for curcumin delivery for therapeutical purposes. A systematic search was performed in PubMed, EMBASE, Web of Science Core Collection, and Google Scholar (January 16, 2025). Two independent reviewers selected studies, and data were synthesized descriptively. Bibliometric analysis was conducted using VOSviewer. From 5336 records, 387 studies met inclusion criteria. Cancer (212 studies) and wound healing (112 studies) were the predominant topics. Co‐occurrence analysis revealed curcumin, chitosan, and drug delivery as the main reported keywords. In cancer treatment, compiled evidence from in vitro and animal suggests that chitosan‐based nanoparticles enhanced curcumin's bioavailability, cytotoxicity, and therapeutic effect. The treatment was often applied in synergy with agents like 5‐fluorouracil, methotrexate, and paclitaxel. In wound healing, hydrogels, scaffolds, nanofibers, and films improved biocompatibility, antibacterial properties, and regenerative capacity, especially for diabetic wounds and burns. In some cases, the treatment incorporated other bioactives like EGF, exosomes, or aloe vera. Chitosan‐based formulations containing curcumin have demonstrated strong potential in cancer treatment and wound healing care.
- 27 January 2025
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 54 (2) , 112-119
PETRICCS Guideline Protocol: A Call to Improve Reporting Standards in Cell Culture Research
Background: Cell culture studies play an important role in addressing fundamental scientific questions. However, inadequate reporting of these studies results in a lack of transparency and reproducibility. Recognizing the need for improvement, several ongoing efforts, such as CRIS guidelines and the ICLAC checklist, are focused on enhancing best practices for in vitro studies. Nonetheless, a comprehensive guideline specifically addressing the reporting of cell culture methods remains lacking. In this manner, a consensus‐based approach is being undertaken to develop the Preferred and Transparent Reporting Items for Cell Culture Studies (PETRICCS) guideline. This project aims to present the protocol and the details for its development.Methods: The process comprises five phases: (i) Initial Steps: a Steering Committee identifies the need for a guideline and drafts the PETRICCS protocol; (ii) Pre‐meeting: an International Group of Cell Culture Experts (IGCE) reviews the draft guideline through a Delphi consensus exercise; (iii) Consensus Meeting: the steering committee presents the guideline's development, addresses concerns, and reaches consensus on the final items; (iv) Post‐meeting: explanatory documents are prepared to assist authors in reporting their findings; and (v) Post‐publication: PETRICCS, along with supporting documents, is published and made freely accessible.Results and Conclusions: PETRICCS will assist researchers in reporting and reviewing cell culture findings, enhancing transparency and reproducibility while filling a gap in this crucial scientific field. The guideline will incorporate the experiences of experts, creating a more equitable environment for authors, peer‐reviewers, and editors during the publication process.
- 27 January 2025
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 54 (2) , 112-119
PETRICCS Guideline Protocol: A Call to Improve Reporting Standards in Cell Culture Research
Background: Cell culture studies play an important role in addressing fundamental scientific questions. However, inadequate reporting of these studies results in a lack of transparency and reproducibility. Recognizing the need for improvement, several ongoing efforts, such as CRIS guidelines and the ICLAC checklist, are focused on enhancing best practices for in vitro studies. Nonetheless, a comprehensive guideline specifically addressing the reporting of cell culture methods remains lacking. In this manner, a consensus‐based approach is being undertaken to develop the Preferred and Transparent Reporting Items for Cell Culture Studies (PETRICCS) guideline. This project aims to present the protocol and the details for its development.Methods: The process comprises five phases: (i) Initial Steps: a Steering Committee identifies the need for a guideline and drafts the PETRICCS protocol; (ii) Pre‐meeting: an International Group of Cell Culture Experts (IGCE) reviews the draft guideline through a Delphi consensus exercise; (iii) Consensus Meeting: the steering committee presents the guideline's development, addresses concerns, and reaches consensus on the final items; (iv) Post‐meeting: explanatory documents are prepared to assist authors in reporting their findings; and (v) Post‐publication: PETRICCS, along with supporting documents, is published and made freely accessible.Results and Conclusions: PETRICCS will assist researchers in reporting and reviewing cell culture findings, enhancing transparency and reproducibility while filling a gap in this crucial scientific field. The guideline will incorporate the experiences of experts, creating a more equitable environment for authors, peer‐reviewers, and editors during the publication process.
- 31 December 2024
- Published by Elsevier in Archives of Oral Biology
- Vol. 172, 106172
Effects of ionizing radiation on osteoblastic cells: In vitro insights into the etiopathogenesis of osteoradionecrosis
- 31 December 2024
- Published by Elsevier in Archives of Oral Biology
- Vol. 172, 106172
Effects of ionizing radiation on osteoblastic cells: In vitro insights into the etiopathogenesis of osteoradionecrosis
- Open Access
- 26 December 2024
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (1) , 18
Bioadhesive Chitosan Films Loading Curcumin for Safe and Effective Skin Cancer Topical Treatment
Background/Objectives: This study aimed to evaluate the safety and efficacy of chitosan-based bioadhesive films for facilitating the topical delivery of curcumin in skin cancer treatment, addressing the pharmacokinetic limitations associated with oral administration. Methods: The films, which incorporated curcumin, were formulated using varying proportions of chitosan, polyvinyl alcohol, Poloxamer® 407, and propylene glycol. These films were assessed for stability, drug release, in vitro skin permeation, cell viability (with and without radiotherapy), and skin irritation. Results: The films demonstrated physical stability and preserved curcumin content at room temperature for 90 days. Drug release was effectively controlled during the first 8 h, with release rates ranging from 51.6 ± 4.8% to 65.6 ± 13.0%. The films also enhanced drug penetration into the skin compared to a curcumin solution used as a control (stratum corneum: 1.3 ± 0.1 to 1.9 ± 0.8 µg/cm²; deeper skin layers: 1.7 ± 0.1 to 2.7 ± 0.2 µg/cm²). A cytotoxicity test on metastatic melanoma cells showed that curcumin at topical doses exerted activity similar to that delivered via the skin. Furthermore, curcumin alone was more effective in inhibiting tumor cells than radiotherapy alone (p < 0.01), with no additional benefit observed when curcumin was combined with radiotherapy. Finally, irritation tests confirmed that the films were safe for topical application. Conclusion: The developed chitosan-based bioadhesive films represent a promising alternative for the topical treatment of skin tumors using curcumin.
- 26 December 2024
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (1) , 18
Open AccessBioadhesive Chitosan Films Loading Curcumin for Safe and Effective Skin Cancer Topical Treatment
Background/Objectives: This study aimed to evaluate the safety and efficacy of chitosan-based bioadhesive films for facilitating the topical delivery of curcumin in skin cancer treatment, addressing the pharmacokinetic limitations associated with oral administration. Methods: The films, which incorporated curcumin, were formulated using varying proportions of chitosan, polyvinyl alcohol, Poloxamer® 407, and propylene glycol. These films were assessed for stability, drug release, in vitro skin permeation, cell viability (with and without radiotherapy), and skin irritation. Results: The films demonstrated physical stability and preserved curcumin content at room temperature for 90 days. Drug release was effectively controlled during the first 8 h, with release rates ranging from 51.6 ± 4.8% to 65.6 ± 13.0%. The films also enhanced drug penetration into the skin compared to a curcumin solution used as a control (stratum corneum: 1.3 ± 0.1 to 1.9 ± 0.8 µg/cm²; deeper skin layers: 1.7 ± 0.1 to 2.7 ± 0.2 µg/cm²). A cytotoxicity test on metastatic melanoma cells showed that curcumin at topical doses exerted activity similar to that delivered via the skin. Furthermore, curcumin alone was more effective in inhibiting tumor cells than radiotherapy alone (p < 0.01), with no additional benefit observed when curcumin was combined with radiotherapy. Finally, irritation tests confirmed that the films were safe for topical application. Conclusion: The developed chitosan-based bioadhesive films represent a promising alternative for the topical treatment of skin tumors using curcumin.
- 18 July 2023
- Published by Wiley in Research Synthesis Methods
- Vol. 14 (6) , 776-793
Critical appraisal tools used in systematic reviews of in vitro cell culture studies: A methodological study
Systematic reviews (SRs) of preclinical studies are marked with poor methodological quality. In vitro studies lack assessment tools to improve the quality of preclinical research. This methodological study aimed to identify, collect, and analyze SRs based on cell culture studies to highlight the current appraisal tools utilized to support the development of a validated critical appraisal tool for cell culture in vitro research. SRs, scoping reviews, and meta‐analyses that included cell culture studies and used any type of critical appraisal tool were included. Electronic search, study selection, data collection and methodological quality (MQ) assessment tool were realized. Further, statistical analyses regarding possible associations and correlations between MQ and collected data were performed. After the screening process, 82 studies remained for subsequent analysis. A total of 32 different appraisal tools were identified. Approximately 60% of studies adopted pre‐structured tools not designed for cell culture studies. The most frequent instruments were SYRCLE (n = 14), OHAT (n = 9), Cochrane Collaboration's tool (n = 7), GRADE (n = 6), CONSORT (n = 5), and ToxRTool (n = 5). The studies were divided into subgroups to perform statistical analyses. A significant association (OR = 5.00, 95% CI = 1.54–16.20, p = 0.008) was found between low MQ and chronic degenerative disorders as topic of SR. Several challenges in collecting information from the included studies led to some modifications related to the previously registered protocol. These results may serve as a basis for further development of a critical appraisal tool for cell culture studies capable of capturing all the essential factors related to preclinical research, therefore enhancing the practice of evidence‐based.
- 18 July 2023
- Published by Wiley in Research Synthesis Methods
- Vol. 14 (6) , 776-793
Critical appraisal tools used in systematic reviews of in vitro cell culture studies: A methodological study
Systematic reviews (SRs) of preclinical studies are marked with poor methodological quality. In vitro studies lack assessment tools to improve the quality of preclinical research. This methodological study aimed to identify, collect, and analyze SRs based on cell culture studies to highlight the current appraisal tools utilized to support the development of a validated critical appraisal tool for cell culture in vitro research. SRs, scoping reviews, and meta‐analyses that included cell culture studies and used any type of critical appraisal tool were included. Electronic search, study selection, data collection and methodological quality (MQ) assessment tool were realized. Further, statistical analyses regarding possible associations and correlations between MQ and collected data were performed. After the screening process, 82 studies remained for subsequent analysis. A total of 32 different appraisal tools were identified. Approximately 60% of studies adopted pre‐structured tools not designed for cell culture studies. The most frequent instruments were SYRCLE (n = 14), OHAT (n = 9), Cochrane Collaboration's tool (n = 7), GRADE (n = 6), CONSORT (n = 5), and ToxRTool (n = 5). The studies were divided into subgroups to perform statistical analyses. A significant association (OR = 5.00, 95% CI = 1.54–16.20, p = 0.008) was found between low MQ and chronic degenerative disorders as topic of SR. Several challenges in collecting information from the included studies led to some modifications related to the previously registered protocol. These results may serve as a basis for further development of a critical appraisal tool for cell culture studies capable of capturing all the essential factors related to preclinical research, therefore enhancing the practice of evidence‐based.
- 7 June 2022
- Published by Springer Nature in Lasers in Dental Science
- Vol. 6 (3) , 205-210
Effects of different photobiomodulation therapy doses on cell viability after bacterial and ionizing radiation–induced stress: a pilot in vitro study
- 7 June 2022
- Published by Springer Nature in Lasers in Dental Science
- Vol. 6 (3) , 205-210
Effects of different photobiomodulation therapy doses on cell viability after bacterial and ionizing radiation–induced stress: a pilot in vitro study